{
  "id": "clinical#screening_cues_8837e1ff",
  "content": "of developing a variety of medical conditions affecting the cardiovascular system (e.g.\nhypertension) and metabolism (e.g. hyperglycaemia), some of which may be due to the\neffects of the chronic use of medications used to treat bipolar disorders.\n• Individuals with bipolar type I or bipolar type II disorder exhibit high rates of co-occurring\nmental, behavioural and neurodevelopmental disorders, most commonly anxiety and fear-\nrelated disorders and disorders due to substance use.\nBoundary with normality (threshold) for bipolar type I and bipolar\ntype II disorders\n• The presence or history of hypomanic episodes in the absence of a history of at least\none depressive episode is not a sufficient basis for a presumptive diagnosis of bipolar\ntype II disorder.\nCulture-related features for bipolar type I and bipolar type II disorders\n• Studies indicate that the prevalence of bipolar and related disorders varies across cultural,\nethnic and migrant groups, partly as a function of social stress. Symptom expression\nmay also vary and be shaped by common cultural idioms, cultural histories or personal\nhistories that are prominent in identity formation and expressed as grandiose ideas or\nbeliefs. For example, grandiosity may be expressed in culturally specific ways such that",
  "metadata": {
    "source": "WHO ICD-11",
    "url": "https://icd.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "stress",
      "study",
      "communication_tips",
      "screening_cues",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues of developing a variety of medical conditions affecting the cardiovascular system (e.g.\nhypertension) and metabolism (e.g. hyperglycaemia), some of which may be due to the\neffects of the chronic use of medications used to treat bipolar disorders.\n• Individuals with bipolar type I or bipolar type II disorder exhibit high rates of co-occurring\nmental, behavioural and neurodevelopmental disorders, most commonly anxiety and fear-\nrelated disorders and disorders due to substance use.\nBoundary with normality (threshold) for bipolar type I and bipolar\ntype II disorders\n• The presence or history of hypomanic episodes in the absence of a history of at least\none depressive episode is not a sufficient basis for a presumptive diagnosis of bipolar\ntype II disorder.\nCulture-related features for bipolar type I and bipolar type II disorders\n• Studies indicate that the prevalence of bipolar and related disorders varies across cultural,\nethnic and migrant groups, partly as a function of social stress. Symptom expression\nmay also vary and be shaped by common cultural idioms, cultural histories or personal\nhistories that are prominent in identity formation and expressed as grandiose ideas or\nbeliefs. For example, grandiosity may be expressed in culturally specific ways such that Of developing a variety of medical conditions affecting the cardiovascular system (e.g. hypertension) and metabolism (e.g."
}